FDA Approves Drug That Helps Detect Alzheimer’s
PROVIDENCE, R.I (WLNE) – The FDA has approved a new drug studied by doctors at both Rhode Island and Butler Hospitals, in hopes of finding a possible cure to Alzheimer’s disease.
The new drug, the first of its kind, will be able to confirm the presence of a certain protein in the brain which may lead to an Alzheimer’s diagnosis in patients suspected of having the disease.
Butler Hospital was one of 27 study sites across the country to take part in the study and brain imaging was conducted by staff at Rhode Island Hospital.
Dr. Jonathan Drake of RIH Alzheimer’s Disease and Memory Disorders Center said the drug can help image the tau protein that builds in Alzheimer’s disease, which normally would only be visible through invasive methods such as a lumbar puncture to get spinal fluid or a brain autopsy.
Drake said the drug represents a significant leap forward.